Embed This Video

<object id="cnbcplayer" height="380" width="400" classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=9,0,0,0" > <param name="type" value="application/x-shockwave-flash"/> <param name="allowfullscreen" value="true"/> <param name="allowscriptaccess" value="always"/> <param name="quality" value="best"/> <param name="scale" value="noscale" /> <param name="wmode" value="transparent"/> <param name="bgcolor" value="#000000"/> <param name="salign" value="lt"/> <param name="flashVars" value="startTime=000"/> <param name="flashVars" value="endTime=000"/> <param name="movie" value="http://plus.cnbc.com/rssvideosearch/action/player/id/3000211868/code/cnbcplayershare" /> <embed name="cnbcplayer" PLUGINSPAGE="http://www.macromedia.com/go/getflashplayer" allowfullscreen="true" allowscriptaccess="always" bgcolor="#000000" height="380" width="400" quality="best" wmode="transparent" scale="noscale" salign="lt" src="http://plus.cnbc.com/rssvideosearch/action/player/id/3000211868/code/cnbcplayershare" type="application/x-shockwave-flash" /></object>

Link To This Video

test

Rate This Video

2 Stars

3 Stars

4 Stars

5 Stars

(No Ratings Yet)

Loading...

Tags For This Video

Novo Nordisk CEO on Generic Drug Impact

Posted on Nov 13, 2013 in Business News, Economy, Strategy, Supply Chain, Sustainability, Technology

Novo Nordisk CEO on Generic Drug Impact

Jesper Brandgaard, CFO of Novo Nordisk, says that the company will counter the loss of insulin market share with a longer acting insulin, but the tablet form is still a few years away.

Related Posts